SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Nov. 3, 2021 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today announced its financial results for the quarter ended September 30, 2021. Total revenue in the third quarter of 2021 grew 17% year over […]
Financial
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update
On-going Phase 2b clinical trial (ASPEN-COVID-19) evaluating rNAPc2 as a potential treatment for COVID-19 DSMC interim analysis of safety and efficacy data from ASPEN-COVID-19 completed with recommendation to continue trial to completion with no modifications Topline data anticipated in first quarter of 2022 Cash and cash equivalents of $58.3 million […]
Amarin Reports Third Quarter 2021 Financial Results and Provides Business Update
Launched VAZKEPA in Germany with Multiple European Country Launches Expected in 2022 Introduced New Go-to-Market Strategy in U.S. to Enhance Awareness and Drive Demand for VASCEPA® Plans for Regulatory Filings and Approvals of VASCEPA in Several Additional Countries in 2022 Company to Host Conference Call Today at 7:30 a.m. ET DUBLIN, […]
CMS Sets National Payment Rate for the HeartFlow Analysis in Doctors’ Offices and Imaging Centers
REDWOOD CITY, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the Centers for Medicare & Medicaid Services (CMS) have established a national payment rate of $930.34 for the HeartFlow FFRct Analysis in office-based settings, such as doctors’ offices and imaging centers, […]
Novo Nordisk’s net profit increased by 12% in the first nine months of 2021
Financial report for the period 1 January 2021 to 30 September 2021 3 November 2021 Novo Nordisk’s net profit increased by 12% in the first nine months of 2021 Operating profit increased by 5% in Danish kroner and by 12% at constant exchange rates (CER). Sales increased by 8% in […]
Zynex Celebrates 25th Anniversary
ENGLEWOOD, Colo., Nov. 3, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced its 25th anniversary. The company was founded in 1996 by current CEO and Chairman Thomas Sandgaard in a one-bedroom […]
Stamford Health Forges New Relationship with Columbia University Irving Medical Center to Expand World-Class Heart Surgery Capabilities
STAMFORD, CT/ NOVEMBER 3, 2021— Stamford Health, known for its award-winning cardiac care through the Heart & Vascular Institute, has expanded its relationship with Columbia University to offer treatment and expertise from Columbia University Irving Medical Center’s nationally recognized heart surgeons. As a result of this new relationship, five of […]
Cordis Names Muscari President Of The Americas
Matthew Muscari takes the helm of global marketing and American sales as Cordis pursues path of transformation and growth MIAMI LAKES, Fla., Nov. 2, 2021 /PRNewswire/ — Cordis, a global interventional vascular technology company, today announced that Matthew Muscari will assume the role of President of the Americas, heading a leadership team responsible […]
Cytokinetics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 29, 2021 it granted stock options to purchase an aggregate of 68,550 shares of common stock to 8 new employees, whose employment commenced in October 2021, as a material inducement to […]
Esperion Reports Third Quarter 2021 Financial Results and Provides Company Update
– Recently Announced Transformative Plan to Align Operational and Expense Structure to the Current Environment and Position for Long-Term Growth – – Unprecedented CLEAR Outcomes Study Remains On-Track for Complete Major Adverse Cardiac Events (MACE) Accumulation in 2H 2022; Achieved 80% MACE Accumulation in October – – U.S. Net Product Revenue […]
